GW Pharmaceutical: A Cut Above the Rest September 28, 2016 Rob Meagher Company Stories, Science and Technology 0 Comments I think Forbes said it best in Debra Borchardt's recent article, "GW Pharmaceutical Gets Closer To Forcing FDA On Cannabis," with an  announcement a couple of weeks ago that its Clinical Phase 3 trial results for Epidolex were positive in paving… Read More→